BRS6(FM1) - Glycaemic–Insulin Stability & Cognitive Energy Availability
(Steady Blood Sugar for Brain Fuel)
1. Definition
Supports integrated regulation of glucose appearance, glycaemic stability, and insulin-supported glucose disposal across the post-prandial period — influencing metabolic continuity, reactive neuroendocrine demand, and cognitive energy availability.
- Regulates the rate and profile of glucose appearance after meals.
- Limits glycaemic variability and post-prandial glucose oscillation.
- Supports insulin-sensitive glucose clearance and utilisation.
2. Primary Biological Effects
↑ post-prandial metabolic stability; ↓ glycaemic volatility; ↓ reactive catecholamine demand; ↑ continuity of cognitive energy availability
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Glucose appearance kinetics, glycaemic variability control, and insulin-mediated glucose disposal jointly shape the metabolic fuel context required for steadier cognitive energy availability. Human cerebral glucose and dietary glycaemic evidence supports low–medium biological relevance within BRAIN without claiming glycaemic diets treat ADHD.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Steadier post-meal glucose appearance and reduced glycaemic volatility help limit metabolic swings that can destabilise attention under cognitive demand. Dietary-pattern and cerebral metabolic association evidence supports low–medium framing for focus stability as an integrated FM outcome.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Insulin sensitivity and glucose disposal capacity support longer-term metabolic resilience that keeps energy allocation adaptable under repeated demand. Metabolic comorbidity and bridging reviews support low–medium biological relevance; ADHD-specific metabolic-resilience trials on this FM remain limited.
- Key References:
- Evidence Confidence: Low–Medium
4. Mechanistic Basis (Integrated FM Narrative)
Glycaemic–insulin stability & cognitive energy availability emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
4.1 Core Primary Mechanisms
-
BRS6-FM1-PM1 — Glucose Appearance Kinetics Regulation of the rate and temporal profile of glucose appearance following feeding through digestion kinetics, gastric emptying, intestinal absorption, food structure, and meal-context effects.
-
BRS6-FM1-PM2 — Glycaemic Variability Regulation Regulation of the stability, volatility, and oscillatory behaviour of post-prandial glucose dynamics across the meal period.
-
BRS6-FM1-PM3 — Insulin Sensitivity & Glucose Disposal Capacity to clear and utilise circulating glucose efficiently after nutrient intake through insulin-responsive tissues, hepatic and muscle glucose handling, and broader metabolic context, reducing prolonged post-prandial strain and supporting metabolic recovery.
4.2 Integrated Functional Narrative
Together, these PMs operationalise BRS6(FM1) as coordinated glycaemic–insulin stability and cognitive energy availability.
4.3 Suboptimal Function & Its Effects
Glycaemic–insulin stability & cognitive energy availability may weaken when glucose / energy substrate availability declines or when refined high-glycaemic carbohydrate loads without buffering macronutrients.
Refined high-glycaemic carbohydrate loads without buffering macronutrients may reduce BRS6(KC1) — Glucose / Energy Substrate Availability. Acute glucose fluctuations that amplify oxidative and metabolic stress relative to sustained hyperglycaemia alone may further strain pool availability, erratic meal timing and skipped meals, ultra-processed low-fibre meal patterns, chronic energy deficit or prolonged underfeeding, while inflammatory and oxidative load increasing metabolic demand.
These pressures may impair BRS6-FM1-PM1 — Glucose Appearance Kinetics, weaken BRS6-FM1-PM2 — Glycaemic Variability Regulation, and reduce the effectiveness of BRS6-FM1-PM3 — Insulin Sensitivity & Glucose Disposal. At the FM level, this may shift BRS6(FM1) toward reduced glycaemic–insulin stability & cognitive energy availability performance.
4.4 Evidence Highlights
Introduction/Summary
The studies below support glycaemic–insulin stability & cognitive energy availability as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Higher dietary fibre intake reduces post-prandial glucose responses through delayed gastric emptying and attenuated intestinal glucose absorption — supporting food-matrix buffering as a lever for glucose appearance kinetics rather than carbohydrate quantity alone [Reynolds et al., 2019].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Preloading protein, fat, or fibre before carbohydrate intake can increase GLP-1 secretion, delay gastric emptying, and attenuate the rate of post-prandial glucose appearance through coordinated incretin and absorption-kinetics effects [Kubota et al., 2020].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Acute glucose fluctuations activate oxidative stress more strongly than sustained hyperglycaemia, supporting glycaemic variability — not mean glucose alone — as a biologically meaningful regulatory target within BRS6(FM1) [Monnier et al., 2006].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: The frequency, magnitude, and duration of glucose excursions across feeding cycles contribute to metabolic stability and reactive physiological stress demand independently of average glucose exposure [Monnier et al., 2006].
- Key References:
5. Connected Mechanisms
- BRS4(FM1) — Cellular Bioenergetics — Cellular Bioenergetics
6. References
- Monnier et al. (2006) — Activation of Oxidative Stress by Acute Glucose Fluctuations Compared with Sustained Chronic
- Reynolds et al. (2019) — A Series of Systematic Reviews and Meta-analyses.
- Johnston et al. (2004) — Vinegar Improves Insulin Sensitivity to a High-carbohydrate Meal in Subjects with Insulin
- Mikus et al. (2012) — Glycaemic Control Is Improved by 7 Days of Aerobic Exercise Training in
- Kubota et al. (2020) — An Attractive Dietary Approach to Prevention and Management of Type 2 Diabetes
- Fanelli et al. (2022) — Insulinopathies of the Brain? Genetic Overlap Between Somatic Insulin-related and Neuropsychiatric Disorders
- Crosby et al. (2021) — Weighing the Benefits Against the Risks
- Zametkin et al. (1990) — Cerebral Glucose Metabolism in Adults with Hyperactivity of Childhood Onset
- Haber et al. (1977) — DEPLETION and DISRUPTION of DIETARY FIBRE
- Gruber et al. (2023) — Impact of Insulin and Insulin Resistance on Brain Dopamine Signalling and Reward
- Wang et al. (2019) — Path Analysis for a Case-Control Study
- Di Girolamo et al. (2022) — Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult
- Marcelli et al. (2025) — Insights Into Shared Mechanisms and Clinical Implications